2026 International Congress Archives - Page 126 of 208

R1 from 18PR04.MZ as a Proxy for Cerebral Blood Flow in Degenerative Parkinsonism: Comparison with 15O-H2O PET/CT.

A. Damian, I. Amorin, V. Kramer, J. Higgie, I. Cordero, L. Gutierrez, E. Savio, T. Arias, O. Alonso, R. Ferrando (Montevideo, Uruguay)
Racial Disparities in End-of-Life Care among Patients with Advanced Movement Disorders in an Interdisciplinary Supportive Care Clinic

K. Sugiura, M. Tharp, M. Husain, A. Hong, Y. Chen, A. Naveed, D. Shankar, K. Gustashaw, S. Chen, G. Hong, J. Fleisher, N. Kramer (Chicago, USA)
Raman Spectroscopic Identification of Biochemical Alterations in Post Mortem Brain Tissue Microarrays from Parkinsons and Alzheimers Disease

A. Omirude, A. Yusuf, S. Eze (Zaria, Nigeria)
Randomized Controlled Trial Comparing Adaptive versus Continuous Subthalamic Nucleus Deep Brain Stimulation in Parkinson’s Disease; Closed Loop Optimization of Deep Brain Stimulation Effect in Parkinson’s Disease (CLOSE-PD study)

J. Genet, M. Heeren, B. Keulen, D. Hubers, B. Swinnen, F. Contarino, M. Janssen, Y. Temel, B. van Wijk, A. Hillebrand, M. Bot, R. Schuurman, R. de Bie, M. Beudel (Amsterdam, Netherlands)
Rare GBA c.1157T>G (p.F386C) Variant in Parkinson’s Disease. Case study.

G. Mussagaliyeva, ZH. Myrzayev, CH. Shashkin, D. Bagautdinov, A. Muratbaikyzy (Almaty, Kazakhstan)
Rare Heterozygous SLC25A12 Variants Are Associated with Parkinson’s Disease

K. Senkevich, T. Kleinz, N. Brüggemann, ZH. Fang, Z. Gan-Or, N. Mencacci, C. Blauwendraat, H. Morris, S. Judd, T. Gasser, K. Brockmann, P. Pastor, C. Beetz, P. Bauer, P. Heutink, K. Seppi, F. Krismer, C. Klein, J. Trinh, A. Zimprich (Montreal, Canada)
Rare Neurotoxicity of Cotrimoxazole A Movement Disorder Presentation In Elderly Patient

M. Keita Sr, A. Ouedraogo, E E. Fanorena, C. Bekara, M. Abdallah (Bourges, France)
Rare Observations of Sustained Symptomatic Improvement with Botulinum Toxin Type A Injections in Facial and Cervical Dystonia: Case Series

N. Rozenberg, G. Yahalom, D. Segal, L. Barski, V. Livneh, A. Ezra, R. Alcalay, T. Gurevich (Tel Aviv, Israel)
Rare Variant Analysis in Parkinson’s Disease Patients Stratified by Polygenic Risk

S. Kanagasingam, A. Balan, Z. Gan-Or, K. Senkevich (Montréal, Canada)
Rates Of Phenoconvertion And Progression To Functionally Meaningful Impairment In NSD Stage 2B Participants: PPMI cohort

T. Simuni, C. Coffey, M. Brumm, C. Choi, R. Schneider, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, C. Allen-Savietta, B. Wendelberger, A. Crawford, T. Tropea, K. Fabrizio, K. Marek (Chicago, USA)
Re-emerging and Emerging Tremor with Postural Changes in Tremor in Dystonia

R. Carandang, P. Panyakeaw (Quezon City, Philippines)
Re-evaluating Olfactory Testing and Cardiac 123I-MIBG Scintigraphy in the MDS Clinical Diagnostic Criteria for Parkinson’s Disease

T. Nukariya, M. Seki, T. Osada, J. Ebina, K. Suzuki, R. Sengoku, T. Hatano, H. Murakami, K. Sakuishi, M. Shiraishi, Y. Shimo, H. Terashi, H. Nagayama, H. Nakajima, K. Takahashi, S. Nogawa, Y. Okuma, F. Yoshii, M. Iijima, N. Hattori (Tokyo, Japan)
Real-life accelerometer-based detection of DBS effects on tremor and dyskinesia in Parkinson’s disease, trained with ecological momentary assessments

J. Habets, V. Mathiopoulou, L. Drescher, A. Ben Janet, A. Buchwald, L. Muessig, J. Kaplan, A. Memarpouri, J. Vivien, L. Feldmann, G. Brandt, A. Kühn (Berlin, Germany)
Real-Time Quaking-Induced Conversion Detection of Tear Fluid α-Synuclein as a Potential Biomarker for Parkinson’s Disease

A. Kakimoto, K. Satoh, T. Tsukahara-Kawamura, Y. Tsuboi (Bunkyo-ku, Japan)
Real-World Clinical Experience With Continuous Subcutaneous Foslevodopa/Foscarbidopa Infusion In Advanced Parkinson’s Disease Patients With Mild Cognitive Impairment And History Of Psychosis

MN. Afkir Ortega, E. Navarro Mocholi, I. Sastre Bataller, M. Campins Romeu, C. Morata Martínez, R. Baviera Muñoz, J. Perez Garcia, I. Martinez Torres (Valencia, Spain)
Real-World Clinical Outcomes and Patient Experience Following Hybrid DBS Conversion to a Neurostimulator with Advanced Current Steering

J. Vesper, A. Dreyer, R. Shivacharan, E. Goldberg (Düsseldorf, Germany)
Real-World Clinical Outcomes of Adaptive versus Continuous Deep Brain Stimulation in Early-Stage Parkinson’s Disease: A Systematic Review and Meta-Analysis of 2024-2025 Trials

F. Al-Zaidi (Almaty, Kazakhstan)
Real-world database analysis of new-onset hypotension and medications for orthostatic hypotension prescribing patterns in patients with Parkinson’s Disease receiving MAO-B Inhibitors and levodopa in Japan

M. Nagai, R. Ando, K. Sasaki, Y. Tomita, K. Daidoji, Y. Kogo, T. Ishida (Ehime, Japan)
Real-World Digital Tracking of Parkinson’s Disease

K. Muhammed, S. Mason, A. Graham, A. Macerollo, A. Hulejczuk, J. Cosgrove, D. El Kodsi, V. Khurana, M. Hu, M. Tagliati (London, United Kingdom)
Real-World Effectiveness and Safety of Deutetrabenazine in Chinese Patients With Tardive Dyskinesia

Q. Bo, A. Li, W. Dun, X. Zhang, Z. Wang, J. Li, L. Wang, W. Li, N. Li, Y. Tan, X. Xu, J. Qu, Y. Li, G. Zhang, K. Tugrul Ustundag, A. Peyser Levin, R. Ribalov, W. Lou, R. Eshet, M. Zeygarnik (Beijing, China)
Real-World Evaluation of Deutetrabenazine for Huntington Disease–Associated Chorea in South Korea: Study Design and Baseline Characteristics

M. Jung, R. Eshet, K. Tuğrul üstündağ, A. Peyser Levin (Seoul, Republic of Korea)
Real-World Experience with Continuous Subcutaneous Foslevodopa/Foscarbidopa (FLC/FCD) in Advanced Parkinson’s Disease: A Single-Centre Cohort Study

K. Waqar, M. Thomas, Y. Abdelmajid, E. Freitas, R. Cabrito, RH. Battah, A. Anjum, SH. Mittal (Abu Dhabi, United Arab Emirates)
Real-World Impact of “Off” Time Reduction with Foslevodopa/Foscarbidopa in Advanced Parkinson’s Disease: Post Hoc Analysis of the ROSSINI Study

W. Jost, T. Henriksen, S. Hassin-Baer, R. Hauser, L. Bergmann, M. O'Meara, S. Pan, J. Parra, M. Shah, J. Aldred (Wolfach, Germany)
Real-World Mobile Voice Classification for Parkinson’s Disease Using Convolutional Neural Networks and Mel-Spectrogram Features

N. Leabthong, J. Sringean, T. Laosombut, N. Jeh-Voh1, Z. Win, P. Rattanajun, S. Phumphid, C. Anan, J. Meesri, S. Wekhinhiran, O. Phokaewvarangkul, P. Panyakaew, S. Maytharakcheep, P. Jagota, R. Bhidayasiri (Bangkok, Thailand)
Real-World Mobility Measures Reveal Early Indicators of Parkinson’s Disease Risk in Older Women

Y. Udi, P. Wayne, IM. Lee, P. Rist, A. Salomon, E. Gazit, J. Hausdorff, R. Gilad-Bachrach (Tel Aviv, Israel)
Real-World Outcomes with Directional Deep Brain Stimulation Systems Featuring Multiple Independent Current Control: U.S. Experience

M. Okun, K. Foote, T. Zesiewicz, Y. Bezchlibnyk, A. Papanastassiou, O. Vaou, J. Carlson, J. Aldred, V. Krishna, B. Dalm, C. Luca, J. Jagid, J. Durphy, J. Pilitsis, L. Verhagen Metman, S. Sani, D. Kern, S. Ojemann, R. Shivacharan, E. Goldberg (Gainesville, USA)
Real-World Relationship Between Beta-Band LFP Activity and Motor States in Parkinson’s Disease

IMV. Martin, DRM. Rodriguez-Martin, SM. Marco, BT. Tijero, TF. Fernández, RDP. Del Pino, MA. Acera, JCG. Gómez-Esteban, MRL. Ruiz-López (Cornellà de Llobregat, Spain)
Real-World Survival, Healthcare Access, and Medication Patterns in Atypical Parkinsonian Disorders: A Multi-System EHR Analysis

J. Fenn, N. Mcfarland (Gainesville, USA)
Real-World Turning Impairments in Fallers with Parkinson’s Disease

V. Shah, R. Baudier, C. Silva-Batista, A. Ragothaman, P. Carlson-Kuhta, J. Lapidus, F. Horak, M. Mancini (Portland, USA)
Real-world variability in dosing of continuous subcutaneous foslevodopa/foscarbidopa infusion in advanced Parkinson’s disease: evidence from a single-center cohort

I. Murasan, R. Margarit, R. Radu, L. Ungureanu, S. Berzunteanu, A. Drujescu, D. Batrinu, R. Chiujdea, R. Ilea, S. Diaconu, C. Falup-Pecurariu (Brasov, Romania)
Reasons and Factors Influencing Parkinson’s Patients’ Decision to Decline Deep Brain Stimulation

L. Cabrera, H. King, L. Al Damluji, J. Blumenthal-Barby, B. Levi, S. de Jesus (University Park, USA)
Receptor Selectivity Profile and Clinical Significance of Ecopipam and Its Metabolites as a Potential Therapy for Tourette Syndrome

S. Wanaski, V. Schmith, G. Karkanias, T. Cunniff (Chicago, USA)
Reconfiguration of Structural-Functional Coupling Associated with Clinical Features and 5-Year Progression in Parkinson’s Disease: A Cross-sectional and Longitudinal Study

Y. Li, P. He, L. Wang, K. Nie (Guangzhou, Guangdong Province, China)
Recruitment Strategies in a Diverse Parkinson’s Disease Cohort: Lessons from the East London Parkinson’s Disease Project

KC. Dey, E. Bhadra, A. Zirra, E. Camboe, V. Azoidou, D. Gallagher, T. Boyle, C. Budu, S. Hussain-Ali, CR. Marshall, LJ. Smith, AJ. Noyce (London, United Kingdom)
Redefining Anatomical Boundaries, An Atypical Case of MV-PLUS with Supratentorial extension.

W. Trillo Alvarez, D. Cahuana Ibarra, C. Pinto Torres, C. Ibañez Escalante, K. Choque Pereyra, S. Paliza Huamani, M. Nieto Rosas, S. Meza Caceres, G. Delacuba Vargas, J. Escalante Ortiz, A. Carpio Peña (AREQUIPA, Peru)
Reduced Cardiac MIBG Uptake as a Biomarker for Nucleus Basalis of Meynert Degeneration and Cognitive Impairment in Parkinson’s Disease

T. Ogawa, W. Uchida, K. Kamagata, H. Takeshige-Amano, C. Andica, S. Ueno, W. Sako, S. Aoki, T. Hatano, N. Hattori (Bunkyo-ku, Japan)
Reduced Cholinergic Activity and Electrophysiological Slowing in Patients with GBA-PD

I. Maidan, M. Bouter, A. Mirelman, G. Bonassi, E. Pelosin, L. Avanzino (Tel Aviv, Israel)
Reduced Glucocerebrosidase Activity Is Associated with Cognitive Decline in Severe GBA1-Associated Parkinson’s Disease

D. Macias-Garcia, P. Garcia-Sanz, S. Ojeda-Noda, L. Murillo-Hernández, L. Muñoz-Delgado, A. Adarmes-Gómez, S. Jesus, C. Perez-Calvo, M. San Eufrasio, AM. Castellano-Guerrero, AC. Luque-Ambrosiani, E. Ojeda-Lepe, M. Martín-Bórnez, R. Diaz-Belloso, S. García-Díaz, D. Buiza-Rueda, M. Bonilla-Toribio, R. Pineda-Sanchez, P. Gomez-Garre, P. Mir (Sevilla, Spain)
Reduced Motor Unit Discharge Variability of Wrist Muscles 24 Hours After Closed-Loop Electrical Stimulation in Essential Tremor

X. Yu, N. Kurukuti, H. Hassanlouei, G. Hoo, E. Roth, J. Pons (Jackson, USA)
Reduced Slow Wave Sleep is Associated with Mobility Impairment in People with Parkinson’s Disease

M. Sleyster, A. Miften, A. Amara (Aurora, USA)
Reduced Whole-blood Energy Metabolism in Parkinson’s Disease.

Y. Mizutani, R. Ohdake, Y. Maeda, T. Maeda, R. Nagao, K. Kawabata, S. Shima, A. Ueda, M. Ito, H. Watanabe (Toyoake, Japan)
Reducing Cost and Operative Time in DBS with a Consolidated Workflow: A Time-Driven Activity-Based Costing Analysis

A. Goyal, B. Dong, A. Bansal, M. Marsans, S. Srivatsal, F. Farrokhi (Albany, USA)
Reduction in Dopaminergic Medication in Patients with Parkinson’s Disease Treated with Continuous Apomorphine Infusion versus Subthalamic Nucleus Deep Brain Stimulation: A Cohort Study

L. Reyes, C. Martínez, J. Fonseca, F. Castro, A. Calderon, C. Ramirez (México City, Mexico)
Reframing Treatment Paradigms: The Rise of Cell and Gene Therapies in Parkinson’s Disease

L. Gutiu, A. Fuller, A. Todorova (Durham, USA)
Regional Basal Ganglia Hypoperfusion in Early Parkinson’s Disease: Evidence from CT Perfusion Imaging

FAY. Mallaev, GUL. Rakhimbaeva (Tashkent, Uzbekistan)
Regional Brain Volumes and Network Alterations During Task-Based fMRI in Writer’s Cramp: A Comparison with Healthy Controls

D. Biswas, P. Pankaj, P. Bhat, D. M.R, A. Upadhyay, A. Srivastava, N. Kumar, S. Kumaran, R. Rajan (New Delhi, India)
Regional Distribution and Concordance of Structural MRI and 18F-FDG PET/MRI Findings in Parkinson-Plus Syndromes

A. Gunduz, C. Dönmez, F. Bayır, L. Uslu Beşli, O. şahin, H. Apaydın (Istanbul, Turkey)
Regional Homogeneity in the Visual Network Mediates between Microbiota and Cognition in Parkinson’s Disease

S. Monti, S. Cauzzo, E. Fiorenzato, F. Vianello, P. Mariotto, G. Baruzzo, B. Di Camillo, R. Manara, A. Bertoldo, A. Antonini (Padova, Italy)
Regional landscape of Parkinson’s disease: An update from the NeuRA Natural History of Parkinson’s Study

W. Liu, M. Li, R. Mackinnon, S. Geara, S. Lush, S. Rowe, C. Sue (Randwick, Australia)
Regional α-Synuclein Seeding Activity in Parkinson’s disease and Multiple System Atrophy

D. Kim, D. Yoo, S. An, M. Kang, T. Ahn (Seoul, Republic of Korea)
Regulatory architecture of the SNCA locus in Parkinson’s Disease: Characterization of reported functional mQTL variants in GP2

D. Náfate Wences, A. Cervantes Arriaga, M. Rodríguez Violante, MT. Periñan Tocino, GP2. Genetics Program (Mexico City, Mexico)
Rehabilitation Following Initiation of Device Assisted Treatment in Parkinson’s Disease – a Randomized Controlled Trial

A. Björkdahl, A. Khalif, M. Gustafsson, A. Lindström, F. Bergquist (Gothenburg, Sweden)
Rehabilitation Practices in Parkinson’s Disease in Rome, Italy: Insights from Allied Health Professionals Priot to Implementation of the ParkinsonNet Model (ACTION-PD Project)

D. Genovese, G. Di Lazzaro, P. Zinzi, A R. Bentivoglio, P. Calabresi (Rome, Italy)
Relationship between automatic analysis of gait disorder and eye movement capture by AI and cognitive function in Parkinson’s disease

J. Cheng, JZ. Hu, XY. Cheng, CJ. Mao (Suzhou, China)
Relationship Between Perceived and Actual Gluteal Muscle Activation in Parkinson’s Disease

K. Kakegawa, T. Matsuda, J. Ogawa, Y. Soutome (Bunkyo-ku, Japan)
Relationship Between Psychosocial Factors and Tremor Severity in Essential Tremor

N. Başpınar, T. Akıncı, G. Yüksel (Istanbul, Turkey)
Relationships of serum & CSF Transcobalamin Receptor Antibodies to CSF vitamin B12, holotranscobalamin and clinical progression in Parkinson’s disease

C. Christine, J. Pluvinage, P. Auinger, L. Tat, E. Forti, R. Green, M. Wilson (San Francisco, USA)
REM Sleep Behavior Disorder and Clinical Progression in Multiple System Atrophy

N. Ni, D. Dong, W. Wang, L. Luo (Hanzhou, China)
REM Sleep Behaviour Disorder (RBD) and its relation to Non-motor Symptoms in Progressive Supranuclear Palsy(PSP).

N. Balaini, P. Borse, M. Girija, A. Hynse, R. Paul, A. Kishore (Kochi, India)
REM Sleep Behaviour Disorder and early non-motor symptoms in Parkinson’s Disease

HT. Lim, S. Ng, XY. Choi, D. Heng, ZY. Xu, S. Neo, KY. Tay, WL. Au, DX. Deng, EK. Tan, L. Tan (Singapore, Singapore)
Remaining unmet needs in Essential Tremor and Parkinson’s Disease: European Neurologists’ Assessments of Pharmacologic Response and Advanced Therapy Use

N. Kaempf, á. Sánchez Fraga, C. Tengelin, P. Crivelli, K. Gant, C. Ferrer, A. Grinspan (Frankfurt am Main, Germany)
Remote Digital Deployment of a Validated Psychosis Screener in Parkinson’s Disease: Real-World Feasibility and Screening Yield

A. Hare, S. Shaffer, B. Hood, R. Gilron (San Francisco, USA)
Remote Longitudinal Follow-up of Participants in the Parkinson’s Progression Markers Initiative (PPMI)

C. Tanner, C. Meng, E. Brown, D. Paredes, P. Ranola, G. Windheim, E. Trinh, K. Comyns, J. Ricci, C. Destro, R. Tandon, K. Geisler, A. Siderowf, T. Simuni, K. Marek (San Francisco, USA)
Remotely acquired speech-based biomarkers and their relation to motor and cognitive functions in Parkinson’s disease

A. Jäck, T. Thies, M. Fischer, E. Mallick, L. Marth, O. Wagemann, S. Schönecker, E. Weidinger, U. Fietzek, A. König, N. Linz, J. Tröger, G. Höglinger, J. Levin (Munich, Germany)
Remotely Administered Reaction Time Correlates in Progressive Supranuclear Palsy

T. Siejka, K. Bertram, H. Butzkueven, D. Darby, A. Brodtmann (Melbourne, Australia)
Repetitive Transcranial Magnetic Stimulation Improves Static Balance Control in Cerebellar Ataxia

S. Lee, J. Ro, M. Jung, H-W. Lee (Daegu, Republic of Korea)
Representation of Women in Deep Brain Stimulation Trials in Movement Disorders: Protocol for a Systematic Review and Meta-analysis

D. Garg, M. Auffret, M. Bruno, K. Smilowska, C. Kilbane, W. Kamel, M. Picillo, L. Ali (Delhi, India)
Repurposing Rifabutin for Neuro-Metabolic Disorders: AMPK-PGC-1α-Driven Mitochondrial Protection in Diabetes Associated Parkinsonism

M I. Khan, D. Ahmed (PRAYAGRAJ, India)
Rescue Electrode Implantation after Deep Brain Stimulation in Parkinson’s disease

C. Lazaro-Hernandez, O. Brengaret, A. Cadena, J. Bejarano, A. Martinez, Y. Compta, A. Camara, A. Garrido, C. Painous, E. Muñoz, P. Roldan, J. Rumià, F. Valldeoriola, A. Sanchez (Barcelona, Spain)
RESET-DBS: An exploratory study on the safety and efficacy of personalized burst-patterned deep brain stimulation (DBS) in Parkinson’s Disease (PD)

F. Lange, L. Juarez Paz, P. Köberle, B. Duarte, G. Adacay, T. Sil, M. Reich, A. Kühn, M. Muthuraman, H. Bokil, J. Volkmann (Würzburg, Germany)
Response to symptomatic therapy in Primary Brain Calcification: a cohort survey

G. Bonato, F. Pistonesi, A. Antonini, M. Carecchio (Padova / Milan, Italy)
Responsiveness of a Smartphone-Based Sensor-Derived Composite Endpoint in a Phase 2b Study in Parkinson’s Disease (PD)

R. Llorens Arenas, E. Bartholome, S. Belachew, C. Bernasconi, G. Cosne, A. Ena, J. Guo, B. Hersh, D. Jennings, A. Juraver, C. Kanzler, A. Karatsidis, F. La Pietra, M. Pang, ó. Reyes, A. Rodríguez-Romero, M. Wald, P. Wang, M. Yang, C. Mazzà (Cambridge, USA)
Responsiveness of Sensor-Derived Measures From a Smartphone-Based Active Typing Test in the Phase 2b LUMA Study of Parkinson’s Disease

R. Llorens Arenas, E. Bartholome, S. Belachew, C. Bernasconi, G. Cosne, J. Guo, B. Hersh, D. Jennings, A. Juraver, C. Kanzler, A. Karatsidis, M. Pang, ó. Reyes, A. Rodríguez-Romero, M. Wald, P. Wang, M. Yang, C. Mazzà (Cambridge, USA)
Rest Tremor does Not Predict Response to Focused Ultrasound Thalamotomy in Essential Tremor and Dystonic Tremor

O. Chan, J. Peters, J. Maamary, L. Jones, S. Bolitho, Y. Barnett, B. Jonker, S. Tisch (Darlinghurst, Australia)
Resting-state functional network alterations in early Parkinson’s disease anxiety: a 7T MRI study

G. Carey, S. Michielse, K. Dujardin, M. Kuijf, A. Leentjens (Reims, France)
Resting-state network reorganization following multimodal lifestyle intervention in Parkinson’s disease

A. Aali, J. Kelly, M. Powell, R. Cloke, A. Hashimoto, Y. Wang, A. Kuan, D. Darabi, T. Watson, J. Yu, S. Dhaliwal, K. Pressman-Cyna, M. Williams, M. Paventi, R. Hassen, O. Brigden, J. Stoessl, V. Sossi, M. Mckeown, S. Appel-Cresswell (Vancouver, Canada)
Resting-state pupil fluctuations reflect monoaminergic brainstem dysfunction associated with non-motor symptoms in early Parkinson’s disease

L. Negri, P. Kinz, S. Bokern, V. Buffler, K. Geiger, I. Uras, B. Popa, J. Conrad (Mannheim, Germany)
Restless leg syndrome in Parkinson’s disease: A systematic review on the prevalence, demographic, clinical profile and diagnostic criteria

A. Payus, J. Sringean, R. Bhidayasiri (kota kinabalu, Malaysia)
Restless Limbs Syndrome (RLS) is More Likely a Premotor Symptom of Parkinson’s Disease then a Predisposing Condition.

D. Dickoff (Yonkers, USA)
Restoring Dopaminergic Function: iPSC-derived MSCs Show Therapeutic Promise in Parkinson’s Disease Rat Model

U. Gogoi, R. Ghanty, N. Kamble, V. Holla, R. Yadav, P. Pal, I. Datta (Bengaluru, India)
Restoring the Axis: Efficacy of Fecal Microbiota Transplantation (FMT) on Motor and Non-Motor Symptoms in Parkinson’s Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2023–2025)

Z. Hussein, A. Al-Zaidi, F. Al-Zaidi (Salahddin, Iraq)
Results from a Randomized, Double-Blind, Placebo-Controlled Study of ATH434 in MSA using CSF NfL as a Covariate

D. Claassen, C. Wong, P. Trujillo, M. Bradbury, C. Lucas, D. Stamler (Newark, USA)
Rethinking the Divide: Are Cervical Dystonia and Myofascial Pain Two Sides of the Same Coin?

M. Abdel-Wahab, L. Cloppse, N. Ullah, J. Hascalovici, U. Akbar (Hackensack, USA)
Retrieval-Augmented Generation (RAG) Chatbot for Parkinson’s Disease Patient Education and AI-Assisted Clinical Pre-Assessment

H. Ng, T. Mi, L. Guo, J. Gao, M. Grundy, E. Sierra, J. Wang, M. Mckeown (Vancouver, Canada)
Retrospective Evaluation of microRNA-7-5p and Neuron-Derived α-Synuclein in Prodromal Parkinson’s Disease as Phenoconversion Biomarkers

C. Adams, S. Zadegan, K. Muthiah, P. Velammal, M. Jatty (Memphis, USA)
Retrospective Video-Based Motor Assessment: Feasibility and Inter-Rater Variability in Remote Scoring

O. Hares, R. Singh, E. Nishat, R. Nasir, B. Bridges (Hamilton, Canada)
Reversible encephalitic Parkinsonism due to bilateral substantia nigra lesion showing preserved nigrostriatal dopaminergic activity

B. Ku, M. Seo, J. Lee, H. Ku (Incheon, Republic of Korea)
Reversible Uremic Striatopathy Presenting as Acute Generalized Myoclonus and Chorea in a Patient with End Stage Renal Disease: A video-case report

L. Parajiya, A. Doshi, D. Kapoor, S. Sheth, A. Aggarwal (Mumbai, India)
Revisiting Prodromal Diagnostic Criteria in MSA: The Need for Early MRI-Based Diagnosis

J. Ahn, W. Kim, J. Youn, JH. Cho (Seoul, Republic of Korea)
Revisiting the Association between Estrogen Exposure and Parkinson’s Disease: A Fox Insight Analysis

S. Dharmadhikari, V. Dumoulin, S. Karim, M. Afshari (Chicago, USA)
Rhythmic circular stump movements after traumatic amputation: jumping stump syndrome with rapid remission after botulinum toxin type A

P. Muangsiri, P. Chairangsaris (Bangkok, Thailand)
Risk Factors and Etiologies for Emergency Visit among Parkinson´s Disease Patients: a Narrative Review

R. Ojha, D. Ling, J. Ma, L. Wang, Y. Cao, J. Zhao, C. Yang (Kathmandu, Nepal)
Risk factors and management of postoperative infection following deep brain stimulation – A single center experience

K. Vo, T. Tran (HO CHI MINH, Viet Nam)
Risk factors associated with Parkinson’s disease in the DRC (Case of the Initiative Plus Hospital Center, Kinshasa)

P. Kiatoko, R. Fure (KINSHASA, The Democratic Republic of the Congo)
Risk factors for dysautonomic fluctuations in Mexican PwP

MF. Medina-Pérez, MF. Velasco-Delgado, A. Cervantes-Arriaga, R. Solís-Vivanco, M. Rodríguez-Violante (Mexico City, Mexico)
Risk of Deep Venous Thrombosis in Patients With Parkinson’s Disease: A Meta‑Analysis of Observational Studies

V. Byroju, J. Pitton Rissardo, J. Patino, A. Fornari Caprara, A. Mcgarry, I. Walker (Camden, USA)
Risk of Ischemic Cerebrovascular Events in Patients with Deep Brain Stimulation for Parkinson’s Disease: A Cohort Study

P. Antenucci, M. Paciaroni, A. Gozzi, A. Mechelli, M. Pugliatti, D. Gragnaniello, M. Sensi (Ferrara, Italy)
Risk of Serotonin Syndrome in the Combined Use of Selective Monoamine Oxidase B Inhibitors and Serotonin-acting Antidepressants

RWH. Ho, SL. Ho, SYY. Pang (Hong Kong, Hong Kong)
Risk stratification study of fluid biomarkers for alpha-synucleinopathy with dementia

R. Kamo, A. Okuzumi, H. Takeshige, N. Nishikawa, N. Hattori, T. Hatano (Bunkyo, Japan)
Robot-Assisted Transplantation of Hypoimmune iPSC Derived Dopaminergic Progenitor Cells for Idiopathic Parkinson’s Disease

J. Shi, J. Yu, C. Han, A. Chen, L. Jiao, R. Qian (Hefei, China)
Robot-Assisted Transplantation of Hypoimmune iPSC-Derived Dopaminergic Progenitor Cells for PRKN-EOPD

J. Guo, J. Shi, Y. Zhang, C. Han, L. Yao, L. Jiao, R. Qian, J. Yu, A. Chen (Changsha, China)
Robust Location-Agnostic Turn Speed Estimation to Ensure Consistent Remote Monitoring of Gait Impairment in Parkinson’s Disease

L. Angelini, M. Płonka, N. Napiórkowski, G. Bogaarts, A. Festanti, H. Mikulski, M. Lindemann, F. Lipsmeier (Basel, Switzerland)
Role and significance of C-reactive protein in stages of Parkinson’s disease

R. Matmurodov, S. Jumanazarova, H. Daminova, K. Khalimova (Tashkent, Uzbekistan)
Role of ApoE in α-Synuclein Pathology

A. Jaafar, E. Sierecki (Sydney, Australia)
Role of florzolotau (18F) positron emission tomography in the diagnosis and clinical management of progressive supranuclear palsy: a real-world study

KW. Chan, XY. Li, JY. Lu, C. Zuo, J. Wang, FT. Liu (Shanghai, China)
RTN2 Variants Expand the ALS–Hereditary Spastic Paraplegia Disease Spectrum

A. Orlacchio, S. Ramadan, M. Stasi, A. Meyyazhagan, G. Ribas, C. Evangelisti, M. Miele, R. Miyamoto, T. Kawarai, M. França Jr, J. Pedroso, O. Barsottini, H. Teive, S. Santi, E. Panza (Perugia, Italy)